These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 10205180)

  • 1. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.
    Chen Z; Li Y; Krug RM
    EMBO J; 1999 Apr; 18(8):2273-83. PubMed ID: 10205180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.
    Wang W; Krug RM
    Virology; 1996 Sep; 223(1):41-50. PubMed ID: 8806538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.
    Noah DL; Twu KY; Krug RM
    Virology; 2003 Mar; 307(2):386-95. PubMed ID: 12667806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo.
    Li Y; Chen ZY; Wang W; Baker CC; Krug RM
    RNA; 2001 Jun; 7(6):920-31. PubMed ID: 11421366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective nuclear export of viral mRNAs in influenza-virus-infected cells.
    Chen Z; Krug RM
    Trends Microbiol; 2000 Aug; 8(8):376-83. PubMed ID: 10920397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.
    Nemeroff ME; Barabino SM; Li Y; Keller W; Krug RM
    Mol Cell; 1998 Jun; 1(7):991-1000. PubMed ID: 9651582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeras containing influenza NS1 and HIV-1 Rev protein sequences: mechanism of their inhibition of nuclear export of Rev protein-RNA complexes.
    Chen Z; Li Y; Krug RM
    Virology; 1998 Feb; 241(2):234-50. PubMed ID: 9499798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
    Li S; Min JY; Krug RM; Sen GC
    Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.
    Chien CY; Xu Y; Xiao R; Aramini JM; Sahasrabudhe PV; Krug RM; Montelione GT
    Biochemistry; 2004 Feb; 43(7):1950-62. PubMed ID: 14967035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells.
    Twu KY; Kuo RL; Marklund J; Krug RM
    J Virol; 2007 Aug; 81(15):8112-21. PubMed ID: 17522219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.
    Twu KY; Noah DL; Rao P; Kuo RL; Krug RM
    J Virol; 2006 Apr; 80(8):3957-65. PubMed ID: 16571812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells.
    Kuo RL; Krug RM
    J Virol; 2009 Feb; 83(4):1611-6. PubMed ID: 19052083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cleavage and polyadenylation specificity factor in Xenopus laevis oocytes is a cytoplasmic factor involved in regulated polyadenylation.
    Dickson KS; Bilger A; Ballantyne S; Wickens MP
    Mol Cell Biol; 1999 Aug; 19(8):5707-17. PubMed ID: 10409759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).
    Qiu Y; Krug RM
    J Virol; 1994 Apr; 68(4):2425-32. PubMed ID: 7908060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of poly(A) polymerase is concentrated at sites of RNA synthesis and is associated with domains enriched in splicing factors and poly(A) RNA.
    Schul W; van Driel R; de Jong L
    Exp Cell Res; 1998 Jan; 238(1):1-12. PubMed ID: 9457051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of a nuclear export signal by an adjacent inhibitory sequence: the effector domain of the influenza virus NS1 protein.
    Li Y; Yamakita Y; Krug RM
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4864-9. PubMed ID: 9560194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes.
    Melén K; Kinnunen L; Fagerlund R; Ikonen N; Twu KY; Krug RM; Julkunen I
    J Virol; 2007 Jun; 81(11):5995-6006. PubMed ID: 17376915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.
    Min JY; Li S; Sen GC; Krug RM
    Virology; 2007 Jun; 363(1):236-43. PubMed ID: 17320139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses.
    Yin C; Khan JA; Swapna GV; Ertekin A; Krug RM; Tong L; Montelione GT
    J Biol Chem; 2007 Jul; 282(28):20584-92. PubMed ID: 17475623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for suppression of a host antiviral response by influenza A virus.
    Das K; Ma LC; Xiao R; Radvansky B; Aramini J; Zhao L; Marklund J; Kuo RL; Twu KY; Arnold E; Krug RM; Montelione GT
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13093-8. PubMed ID: 18725644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.